DRKS00017043
Recruiting
N/A
Potential influence of coagulation inhibitionon the perception of fear or aggressiveness
niversitätsklinik für Kardiologie und Angiologie0 sites25 target enrollmentMarch 28, 2019
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- I48
- Sponsor
- niversitätsklinik für Kardiologie und Angiologie
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Treatment group: Patients receiving dabigatran under one of the approved indications, e.g. non\-valvular atrial fibrillation, thrombosis, pulmonary embolism or control group: Patients who, after clarifying questionable cardiac arrhythmias, do not require further drug or pacemaker treatment
Exclusion Criteria
- •a) contraindications for dabigatran, e.g. Hypersensitivity to the active substance or to any of the excipients, severe renal insufficiency (creatinine clearance \[CrCl] \<30 ml / min), acute clinically relevant bleeding, organ damage increasing the risk of bleeding, spontaneous or pharmacological limitation of haemostasis, severe liver disease, concomitant systemically administered ketoconazole, cyclosporin, itraconazole or tacrolimus; Pat. With artificial heart valves.
- •b) Severe infections, trauma, tumors or terminal diseases that affect the brain.
- •c) Lack of consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Assessing the correlations of anticoagulant effects between Thromboelastography [TEG] and anti-Xa activity in patients on therapeutic dose of low-molecular-weight heparin (LMWH)?Acute coronary syndromeBlood - Other blood disordersACTRN12609000055202Hayden White60
Completed
N/A
Evaluation of Hemostatics in coagulation inhibited human blood with viscoelastic testing (ROTEM)R58D68.9Haemorrhage, not elsewhere classifiedCoagulation defect, unspecifiedDRKS00015034Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin40
Active, Not Recruiting
Phase 1
Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)EUCTR2020-002282-33-DECharité - Universitaetsmedizin Berlin400
Completed
N/A
Clinical evaluation on activation of coagulation and fibrinolytic system during major cardiovascular surgerymajor cardiovascular surgery with use of cardiopulmonary bypassJPRN-UMIN000010866Teikyo University Hospital60
Recruiting
Phase 3
The effect of systemic anticoagulants in repairing penetrating upper limb arterial traumaArterial trauma.I23.6IRCT20190717044255N3Arak University of Medical Sciences116